StockTipsArenaBeta

BUY Jubilant Pharmova Limited — Sandeep Jain, Tradeswift

BUYJubilant Pharmova Limited

bySandeep Jain, TradeswiftHorizon: NA (inferred Swing (≤2wk))21 Sept 2026via Zee Business (Live)

Entry₹1,074Inferred
Target₹1,150
Total upside +7.08%
Stop loss₹1,010-5.96% risk
CMP₹1,070.855h ago
Active-0.29%+7.39%upside left 13d left
Follow Sandeep Jain for new calls(19% target hit, 59 closed calls)Get alertsWatch JUBLPHARMA for new buy/sell callsGet alertsSee 1 other Swing call on JUBLPHARMASee 181 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 22 Sept, 9:24 pm IST
3 supporting1 neutral1 opposing
Supports the BUY call (3)

MACD above its signal line — bullish momentum

Technicals · macd·22 Sept · today

Jubilant Pharmova FY26 revenue rises 14%; PAT grows 7%

NewsGoogle News·18 Sept · 4d ago

(opens in new tab)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·15 Sept · 1w ago

Neutral / worth noting (1)

Jubilant Pharmova's US CMO facility gets 'Voluntary Action Indicated' classification

NewsCnbc-Tv18·11 Sept · 2w ago

(opens in new tab)
Weighs against the BUY call (1)

RSI at 82 — overbought territory

Technicals · rsi·22 Sept · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.